Search Results

APS-2-79 hydrochloride 50 mg  | 98.64%

TargetMol

APS-2-79 hydrochloride (APS-2-79 HCl) is a MAPK antagonist that modulating KSR-dependent MAPK signalling by antagonizing RAF heterodimerization as well as the conformational changes required for phosphorylation and activation of KSR-bound MEK.

More Information Supplier Page

APS-2-79 hydrochloride 5 mg  | 98.64%

TargetMol

APS-2-79 hydrochloride (APS-2-79 HCl) is a MAPK antagonist that modulating KSR-dependent MAPK signalling by antagonizing RAF heterodimerization as well as the conformational changes required for phosphorylation and activation of KSR-bound MEK.

More Information Supplier Page

EAI045 5 mg  | 99.73%

TargetMol

EAI045, an allosteric inhibitor, targets towards drug-resistant EGFR mutants but avoids the wild-type receptor.

More Information Supplier Page

EAI045 25 mg  | 99.73%

TargetMol

EAI045, an allosteric inhibitor, targets towards drug-resistant EGFR mutants but avoids the wild-type receptor.

More Information Supplier Page

Clindamycin 25 mg  | 98.04%

TargetMol

Clindamycin dissociates peptidyl-tRNA from the bacterial ribosome, thereby disrupting bacterial protein synthesis. Clindamycin is a semisynthetic broad-spectrum antibiotic produced by chemical modification of the parent compound lincomycin.

More Information Supplier Page